AB023

Xisomab 3G3 · Aronora, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB023, covering 2020-07-22 to 2020-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis [Phase 2]

See pricing